Symbols / NXGL $0.65 -13.04% NEXGEL, Inc.
NXGL Chart
About
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Fundamentals
Scroll to Statements| Market Cap | 5.48M | Enterprise Value | 9.51M | Income | -3.00M | Sales | 11.42M | Book/sh | 0.55 | Cash/sh | 0.04 |
| Dividend Yield | — | Payout | 0.00% | Employees | 19 | IPO | — | P/E | — | Forward P/E | 2.81 |
| PEG | — | P/S | 0.48 | P/B | 1.18 | P/C | — | EV/EBITDA | -3.28 | EV/Sales | 0.83 |
| Quick Ratio | 0.34 | Current Ratio | 1.47 | Debt/Eq | 63.14 | LT Debt/Eq | — | EPS (ttm) | -0.38 | EPS next Y | 0.23 |
| EPS Growth | — | Revenue Growth | -8.10% | Earnings | 2026-05-13 | ROA | -19.54% | ROE | -52.74% | ROIC | — |
| Gross Margin | 39.48% | Oper. Margin | -43.42% | Profit Margin | -26.27% | Shs Outstand | 8.48M | Shs Float | 6.65M | Short Float | 1.18% |
| Short Ratio | 0.13 | Short Interest | — | 52W High | 2.97 | 52W Low | 0.56 | Beta | 0.85 | Avg Volume | 352.44K |
| Volume | 539.28K | Target Price | $2.00 | Recom | None | Prev Close | $0.74 | Price | $0.65 | Change | -13.04% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-12 | main | Maxim Group | Buy → Buy | $2 |
| 2022-02-25 | init | Maxim Group | — → Buy | $6 |
- A $5.5M financing gives NEXGEL 6 regenerative products and a new unit - Stock Titan ue, 21 Apr 2026 13
- NexGel (NXGL) Releases Q4 2025 Earnings: Revenue Down, Losses Narrow, Cash Tight | NXGL Stock News - Quiver Quantitative ue, 31 Mar 2026 07
- NXGL (NexGel Inc) shares fall over 15 percent after Q4 2025 EPS loss lands far below analyst consensus estimates. - Expert Verified Trades - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 20
- NEXGEL, Inc.'s (NASDAQ:NXGL) Shift From Loss To Profit - Yahoo Finance Mon, 22 Dec 2025 08
- Tuesday's after hours session: top gainers and losers - ChartMill ue, 21 Apr 2026 21
- Shareholders get NEXGEL's Celularity transaction update 2 days earlier - Stock Titan Fri, 17 Apr 2026 19
- NEXGEL Secures Strategic Financing and Regenerative Portfolio License - TipRanks ue, 21 Apr 2026 20
- Will NexGel (NXGL) Stock Grow in 2026 | Price at $0.60, Down 5.90% - Insider Info - Cổng thông tin điện tử Tỉnh Sơn La hu, 09 Apr 2026 07
- NexGel (NXGL) Price Target Lowered by Maxim Group | NXGL Stock N - GuruFocus hu, 12 Mar 2026 07
- NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity - GlobeNewswire ue, 31 Mar 2026 07
- NexGel (NXGL) Stock: Why Institutions Own It (Leaps) 2026-04-15 - High Interest Stocks - Cổng thông tin điện tử tỉnh Lào Cai Wed, 15 Apr 2026 13
- NEXGEL, Inc. Announces $1.797 Million Financing for Potential Acquisition in Q1 2026 - Quiver Quantitative ue, 10 Feb 2026 08
- NEXGEL (NASDAQ: NXGL) triples revenue outlook with Celularity deal, $6.9M notes - Stock Titan ue, 21 Apr 2026 20
- NEXGEL drops prior financing plan, pushes Celularity update to April 15 - Stock Titan Wed, 08 Apr 2026 07
- NEXGEL grabs Celularity biomaterials in move expected to turn a profit - Stock Titan ue, 10 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
11.42
+31.46%
|
8.69
+112.47%
|
4.09
+99.66%
|
2.05
|
| Operating Revenue |
|
11.00
+31.53%
|
8.37
+108.89%
|
4.00
+112.81%
|
1.88
|
| Cost Of Revenue |
|
6.91
+16.36%
|
5.94
+59.89%
|
3.71
+107.31%
|
1.79
|
| Reconciled Cost Of Revenue |
|
6.91
+16.36%
|
5.94
+74.81%
|
3.40
+125.48%
|
1.51
|
| Gross Profit |
|
4.51
+64.08%
|
2.75
+634.76%
|
0.37
+46.09%
|
0.26
|
| Operating Expense |
|
7.86
+24.74%
|
6.30
+63.65%
|
3.85
+6.85%
|
3.60
|
| Research And Development |
|
0.00
-97.44%
|
0.08
-24.27%
|
0.10
-71.93%
|
0.37
|
| Selling General And Administration |
|
7.86
+26.27%
|
6.22
+83.17%
|
3.40
+20.67%
|
2.82
|
| Selling And Marketing Expense |
|
—
|
2.22
+404.55%
|
0.44
+0.92%
|
0.44
|
| General And Administrative Expense |
|
—
|
3.69
+24.78%
|
2.96
+24.29%
|
2.38
|
| Salaries And Wages |
|
—
|
1.36
+43.90%
|
0.94
+16.71%
|
0.81
|
| Other Gand A |
|
—
|
2.33
+15.83%
|
2.02
+28.18%
|
1.57
|
| Total Expenses |
|
14.77
+20.67%
|
12.24
+61.80%
|
7.57
+40.21%
|
5.40
|
| Operating Income |
|
-3.35
+5.68%
|
-3.55
-2.21%
|
-3.48
-3.85%
|
-3.35
|
| Total Operating Income As Reported |
|
-3.35
+5.68%
|
-3.55
-2.21%
|
-3.48
-3.85%
|
-3.35
|
| EBITDA |
|
-2.12
+22.01%
|
-2.72
+0.48%
|
-2.73
+12.19%
|
-3.11
|
| Normalized EBITDA |
|
-2.40
+14.17%
|
-2.79
+7.36%
|
-3.02
+0.89%
|
-3.04
|
| Reconciled Depreciation |
|
0.74
+11.28%
|
0.67
+50.11%
|
0.44
+47.18%
|
0.30
|
| EBIT |
|
-2.86
+15.46%
|
-3.38
-6.59%
|
-3.17
+6.95%
|
-3.41
|
| Total Unusual Items |
|
0.28
+258.97%
|
0.08
-72.82%
|
0.29
+541.54%
|
-0.07
|
| Total Unusual Items Excluding Goodwill |
|
0.28
+258.97%
|
0.08
-72.82%
|
0.29
+541.54%
|
-0.07
|
| Special Income Charges |
|
0.16
+1000.00%
|
-0.02
|
0.00
+100.00%
|
-0.15
|
| Other Special Charges |
|
—
|
—
|
—
|
0.15
|
| Restructuring And Mergern Acquisition |
|
0.00
-100.00%
|
0.02
|
0.00
|
—
|
| Net Income |
|
-3.00
+8.56%
|
-3.28
-3.93%
|
-3.16
+33.48%
|
-4.75
|
| Pretax Income |
|
-2.89
+16.46%
|
-3.46
-8.63%
|
-3.19
+32.83%
|
-4.75
|
| Net Non Operating Interest Income Expense |
|
-0.03
+58.02%
|
-0.08
-440.00%
|
-0.01
+98.88%
|
-1.34
|
| Interest Expense Non Operating |
|
0.03
-58.02%
|
0.08
+440.00%
|
0.01
-98.88%
|
1.34
|
| Net Interest Income |
|
-0.03
+58.02%
|
-0.08
-440.00%
|
-0.01
+98.88%
|
-1.34
|
| Interest Expense |
|
0.03
-58.02%
|
0.08
+440.00%
|
0.01
-98.88%
|
1.34
|
| Other Income Expense |
|
0.49
+186.63%
|
0.17
-43.42%
|
0.30
+590.32%
|
-0.06
|
| Other Non Operating Income Expenses |
|
0.21
+126.60%
|
0.09
+452.94%
|
0.02
+466.67%
|
0.00
|
| Gain On Sale Of Security |
|
0.12
+22.92%
|
0.10
-66.55%
|
0.29
+237.65%
|
0.09
|
| Gain On Sale Of Business |
|
0.16
|
0.00
|
—
|
—
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-2.89
+16.46%
|
-3.46
-8.63%
|
-3.19
+32.83%
|
-4.75
|
| Net Income From Continuing Operation Net Minority Interest |
|
-3.00
+8.56%
|
-3.28
-3.93%
|
-3.16
+33.48%
|
-4.75
|
| Net Income From Continuing And Discontinued Operation |
|
-3.00
+8.56%
|
-3.28
-3.93%
|
-3.16
+33.48%
|
-4.75
|
| Net Income Continuous Operations |
|
-2.89
+16.46%
|
-3.46
-8.63%
|
-3.19
+32.83%
|
-4.75
|
| Minority Interests |
|
-0.11
-158.79%
|
0.18
+487.10%
|
0.03
|
0.00
|
| Normalized Income |
|
-3.28
+2.35%
|
-3.36
+2.47%
|
-3.44
+26.43%
|
-4.68
|
| Net Income Common Stockholders |
|
-3.00
+8.56%
|
-3.28
-3.93%
|
-3.16
+33.48%
|
-4.75
|
| Diluted EPS |
|
—
|
-0.50
+10.71%
|
-0.56
+34.12%
|
-0.85
|
| Basic EPS |
|
—
|
-0.50
+10.71%
|
-0.56
+34.12%
|
-0.85
|
| Basic Average Shares |
|
—
|
6.51
+14.81%
|
5.67
+1.74%
|
5.57
|
| Diluted Average Shares |
|
—
|
6.51
+14.81%
|
5.67
+1.74%
|
5.57
|
| Diluted NI Availto Com Stockholders |
|
-3.00
+8.56%
|
-3.28
-3.93%
|
-3.16
+33.48%
|
-4.75
|
| Depreciation Amortization Depletion Income Statement |
|
—
|
0.16
+23.81%
|
0.13
+687.50%
|
0.02
|
| Depreciation And Amortization In Income Statement |
|
—
|
0.16
+23.81%
|
0.13
+687.50%
|
0.02
|
| Other Taxes |
|
—
|
0.16
-29.91%
|
0.22
-44.69%
|
0.41
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
10.46
-4.75%
|
10.98
+10.33%
|
9.96
-3.88%
|
10.36
|
| Current Assets |
|
4.34
-15.17%
|
5.11
+1.23%
|
5.05
-32.68%
|
7.50
|
| Cash Cash Equivalents And Short Term Investments |
|
0.32
-82.46%
|
1.81
-33.07%
|
2.70
-59.15%
|
6.61
|
| Cash And Cash Equivalents |
|
0.32
-82.46%
|
1.81
-33.07%
|
2.70
+145.23%
|
1.10
|
| Cash Financial |
|
0.32
-82.46%
|
1.81
-33.07%
|
2.70
+145.23%
|
1.10
|
| Other Short Term Investments |
|
—
|
—
|
0.00
-100.00%
|
5.51
|
| Receivables |
|
0.67
-27.87%
|
0.93
+47.39%
|
0.63
+185.14%
|
0.22
|
| Accounts Receivable |
|
0.67
-27.87%
|
0.93
+47.39%
|
0.63
+185.14%
|
0.22
|
| Gross Accounts Receivable |
|
0.68
-27.29%
|
0.94
+45.65%
|
0.64
+178.79%
|
0.23
|
| Allowance For Doubtful Accounts Receivable |
|
-0.01
-80.00%
|
-0.01
+54.55%
|
-0.01
-22.22%
|
-0.01
|
| Inventory |
|
2.11
+20.56%
|
1.75
+32.75%
|
1.32
+162.75%
|
0.50
|
| Raw Materials |
|
1.37
+78.67%
|
0.77
-14.46%
|
0.90
+204.75%
|
0.29
|
| Work In Process |
|
0.05
+88.00%
|
0.03
+108.33%
|
0.01
-76.47%
|
0.05
|
| Finished Goods |
|
0.96
-4.19%
|
1.00
+145.83%
|
0.41
+161.54%
|
0.16
|
| Prepaid Assets |
|
0.04
-2.17%
|
0.05
-28.13%
|
0.06
+1.59%
|
0.06
|
| Restricted Cash |
|
0.74
|
0.00
|
—
|
—
|
| Other Current Assets |
|
0.45
-21.84%
|
0.58
+71.73%
|
0.34
+208.26%
|
0.11
|
| Total Non Current Assets |
|
6.12
+4.33%
|
5.87
+19.70%
|
4.90
+71.91%
|
2.85
|
| Net PPE |
|
3.97
+3.41%
|
3.84
+14.46%
|
3.35
+36.45%
|
2.46
|
| Gross PPE |
|
5.34
+9.32%
|
4.88
+19.71%
|
4.08
+33.68%
|
3.05
|
| Accumulated Depreciation |
|
-1.37
-31.00%
|
-1.04
-43.94%
|
-0.73
-22.22%
|
-0.59
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
2.36
+2.30%
|
2.31
+62.44%
|
1.42
+37.50%
|
1.03
|
| Construction In Progress |
|
0.55
+2.82%
|
0.53
+37.47%
|
0.39
+603.64%
|
0.06
|
| Other Properties |
|
2.02
+23.77%
|
1.63
-12.24%
|
1.85
+6.79%
|
1.74
|
| Leases |
|
0.42
+0.00%
|
0.42
+0.00%
|
0.42
+83.77%
|
0.23
|
| Goodwill And Other Intangible Assets |
|
1.81
-6.51%
|
1.94
+33.08%
|
1.45
+339.27%
|
0.33
|
| Goodwill |
|
1.13
+0.00%
|
1.13
+0.00%
|
1.13
+262.70%
|
0.31
|
| Other Intangible Assets |
|
0.68
-15.61%
|
0.81
+147.55%
|
0.33
+1530.00%
|
0.02
|
| Investments And Advances |
|
0.25
|
0.00
|
—
|
—
|
| Long Term Equity Investment |
|
0.25
|
0.00
|
—
|
—
|
| Other Non Current Assets |
|
0.10
+0.00%
|
0.10
+0.00%
|
0.10
+50.79%
|
0.06
|
| Total Liabilities Net Minority Interest |
|
5.57
+13.60%
|
4.90
+2.38%
|
4.79
+76.07%
|
2.72
|
| Current Liabilities |
|
2.96
+19.68%
|
2.47
-3.10%
|
2.55
+196.74%
|
0.86
|
| Payables And Accrued Expenses |
|
1.42
-7.76%
|
1.53
+18.55%
|
1.29
+246.92%
|
0.37
|
| Payables |
|
1.29
-0.23%
|
1.29
+4.79%
|
1.23
+288.96%
|
0.32
|
| Accounts Payable |
|
1.29
-0.23%
|
1.29
+4.79%
|
1.23
+365.28%
|
0.27
|
| Current Accrued Expenses |
|
0.13
-47.93%
|
0.24
+296.72%
|
0.06
+8.93%
|
0.06
|
| Total Tax Payable |
|
—
|
—
|
0.00
-100.00%
|
0.05
|
| Current Debt And Capital Lease Obligation |
|
0.47
+20.61%
|
0.39
-29.57%
|
0.56
+151.35%
|
0.22
|
| Current Debt |
|
0.10
+2.06%
|
0.10
-70.15%
|
0.33
+2066.67%
|
0.01
|
| Other Current Borrowings |
|
0.10
+2.06%
|
0.10
+21.25%
|
0.08
+433.33%
|
0.01
|
| Current Capital Lease Obligation |
|
0.38
+26.69%
|
0.30
+27.04%
|
0.23
+12.56%
|
0.21
|
| Current Deferred Liabilities |
|
0.73
+309.50%
|
0.18
+795.00%
|
0.02
|
0.00
|
| Current Deferred Revenue |
|
0.00
-98.88%
|
0.18
+795.00%
|
0.02
|
0.00
|
| Other Current Liabilities |
|
0.33
-8.24%
|
0.36
-46.23%
|
0.68
+156.44%
|
0.26
|
| Total Non Current Liabilities Net Minority Interest |
|
2.61
+7.44%
|
2.43
+8.62%
|
2.24
+20.37%
|
1.86
|
| Long Term Debt And Capital Lease Obligation |
|
2.61
+7.44%
|
2.43
+8.62%
|
2.24
+20.37%
|
1.86
|
| Long Term Debt |
|
0.49
-16.84%
|
0.59
+14.62%
|
0.51
+91.42%
|
0.27
|
| Long Term Capital Lease Obligation |
|
2.12
+15.18%
|
1.84
+6.83%
|
1.73
+8.41%
|
1.59
|
| Stockholders Equity |
|
4.46
-22.52%
|
5.75
+22.53%
|
4.70
-38.50%
|
7.64
|
| Common Stock Equity |
|
4.46
-22.52%
|
5.75
+22.53%
|
4.70
-38.50%
|
7.64
|
| Capital Stock |
|
0.01
+0.00%
|
0.01
+33.33%
|
0.01
+0.00%
|
0.01
|
| Common Stock |
|
0.01
+0.00%
|
0.01
+33.33%
|
0.01
+0.00%
|
0.01
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
8.14
+6.61%
|
7.64
+33.03%
|
5.74
+2.94%
|
5.58
|
| Ordinary Shares Number |
|
8.14
+6.61%
|
7.64
+33.03%
|
5.74
+2.94%
|
5.58
|
| Additional Paid In Capital |
|
25.45
+7.18%
|
23.74
+22.35%
|
19.41
+1.13%
|
19.19
|
| Retained Earnings |
|
-21.00
-16.67%
|
-18.00
-22.30%
|
-14.71
-27.31%
|
-11.56
|
| Minority Interest |
|
0.43
+32.92%
|
0.33
-30.70%
|
0.47
|
0.00
|
| Total Equity Gross Minority Interest |
|
4.89
-19.56%
|
6.08
+17.69%
|
5.17
-32.36%
|
7.64
|
| Total Capitalization |
|
4.95
-21.99%
|
6.34
+21.75%
|
5.21
-34.09%
|
7.91
|
| Working Capital |
|
1.38
-47.73%
|
2.64
+5.63%
|
2.50
-62.34%
|
6.65
|
| Invested Capital |
|
5.05
-21.63%
|
6.44
+16.35%
|
5.54
-30.11%
|
7.92
|
| Total Debt |
|
3.09
+9.27%
|
2.83
+1.00%
|
2.80
+34.33%
|
2.08
|
| Net Debt |
|
0.27
|
—
|
—
|
—
|
| Capital Lease Obligations |
|
2.50
+16.77%
|
2.14
+9.23%
|
1.96
+8.89%
|
1.80
|
| Net Tangible Assets |
|
2.65
-30.63%
|
3.82
+17.79%
|
3.24
-55.61%
|
7.31
|
| Tangible Book Value |
|
2.65
-30.63%
|
3.82
+17.79%
|
3.24
-55.61%
|
7.31
|
| Current Notes Payable |
|
—
|
—
|
—
|
—
|
| Dueto Related Parties Current |
|
—
|
0.53
-18.81%
|
0.65
|
—
|
| Inventories Adjustments Allowances |
|
-0.27
-489.13%
|
-0.05
|
0.00
|
0.00
|
| Investments In Other Ventures Under Equity Method |
|
0.25
|
0.00
|
—
|
—
|
| Line Of Credit |
|
—
|
0.00
-100.00%
|
0.24
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-1.31
+66.10%
|
-3.87
-19.50%
|
-3.24
-8.16%
|
-2.99
|
| Cash Flow From Continuing Operating Activities |
|
-1.31
+66.08%
|
-3.87
-19.44%
|
-3.24
-8.16%
|
-2.99
|
| Net Income From Continuing Operations |
|
-2.89
+16.46%
|
-3.46
-9.69%
|
-3.16
+33.48%
|
-4.75
|
| Depreciation Amortization Depletion |
|
0.74
+11.28%
|
0.67
+50.11%
|
0.44
+47.18%
|
0.30
|
| Depreciation |
|
0.61
+12.45%
|
0.55
+56.45%
|
0.35
+21.18%
|
0.29
|
| Amortization Cash Flow |
|
0.13
+5.88%
|
0.12
+26.60%
|
0.09
+623.08%
|
0.01
|
| Depreciation And Amortization |
|
0.74
+11.28%
|
0.67
+50.11%
|
0.44
+47.18%
|
0.30
|
| Amortization Of Intangibles |
|
0.13
+5.88%
|
0.12
+26.60%
|
0.09
+623.08%
|
0.01
|
| Other Non Cash Items |
|
—
|
0.02
+151.61%
|
-0.03
-102.34%
|
1.32
|
| Stock Based Compensation |
|
0.65
+78.20%
|
0.37
+69.12%
|
0.22
-27.18%
|
0.30
|
| Operating Gains Losses |
|
-0.28
-191.67%
|
-0.10
+66.55%
|
-0.29
-541.54%
|
0.07
|
| Gain Loss On Investment Securities |
|
-0.12
-22.92%
|
-0.10
+66.55%
|
-0.29
-237.65%
|
-0.09
|
| Change In Working Capital |
|
0.47
+134.51%
|
-1.36
-222.09%
|
-0.42
-79.91%
|
-0.23
|
| Change In Receivables |
|
0.26
+186.67%
|
-0.30
+27.01%
|
-0.41
-3061.54%
|
-0.01
|
| Changes In Account Receivables |
|
0.26
+186.67%
|
-0.30
+27.01%
|
-0.41
-3061.54%
|
-0.01
|
| Change In Inventory |
|
-0.36
+16.67%
|
-0.43
+43.16%
|
-0.76
-260.19%
|
-0.21
|
| Change In Prepaid Assets |
|
0.86
+484.75%
|
-0.22
+14.23%
|
-0.26
-173.68%
|
-0.10
|
| Change In Payables And Accrued Expense |
|
0.15
+139.20%
|
-0.38
-137.88%
|
0.99
+1064.71%
|
0.09
|
| Change In Accrued Expense |
|
0.15
+134.56%
|
-0.43
-2072.73%
|
0.02
-70.27%
|
0.07
|
| Change In Payable |
|
-0.00
-105.08%
|
0.06
-93.90%
|
0.97
+8700.00%
|
0.01
|
| Change In Account Payable |
|
-0.00
-105.08%
|
0.06
-93.90%
|
0.97
+8700.00%
|
0.01
|
| Change In Other Working Capital |
|
-0.18
-211.32%
|
0.16
+695.00%
|
0.02
|
—
|
| Change In Other Current Liabilities |
|
-0.26
-40.54%
|
-0.18
|
—
|
—
|
| Investing Cash Flow |
|
-0.07
+91.23%
|
-0.78
-117.39%
|
4.46
+179.64%
|
-5.59
|
| Cash Flow From Continuing Investing Activities |
|
-0.07
+91.23%
|
-0.78
-117.39%
|
4.46
+179.64%
|
-5.59
|
| Net PPE Purchase And Sale |
|
-0.07
+84.65%
|
-0.44
+36.35%
|
-0.70
-625.00%
|
-0.10
|
| Purchase Of PPE |
|
-0.07
+84.65%
|
-0.44
+36.35%
|
-0.70
-625.00%
|
-0.10
|
| Capital Expenditure |
|
-0.07
+84.65%
|
-0.44
+36.35%
|
-0.70
-625.00%
|
-0.10
|
| Net Investment Purchase And Sale |
|
0.00
-100.00%
|
0.07
-98.81%
|
5.70
+203.64%
|
-5.50
|
| Purchase Of Investment |
|
—
|
—
|
0.00
+100.00%
|
-7.00
|
| Sale Of Investment |
|
0.00
-100.00%
|
0.07
-98.81%
|
5.70
+279.93%
|
1.50
|
| Net Business Purchase And Sale |
|
0.00
+100.00%
|
-0.40
+26.87%
|
-0.55
|
0.00
|
| Purchase Of Business |
|
0.00
+100.00%
|
-0.40
+26.87%
|
-0.55
|
0.00
|
| Gain Loss On Sale Of Business |
|
-0.16
|
0.00
|
—
|
—
|
| Financing Cash Flow |
|
0.63
-83.20%
|
3.75
+889.18%
|
0.38
+110.35%
|
-3.66
|
| Cash Flow From Continuing Financing Activities |
|
0.63
-83.20%
|
3.75
+889.18%
|
0.38
+110.35%
|
-3.66
|
| Net Issuance Payments Of Debt |
|
-0.16
-171.56%
|
0.22
-42.48%
|
0.38
+110.35%
|
-3.66
|
| Issuance Of Debt |
|
0.00
-100.00%
|
0.34
-38.39%
|
0.56
|
0.00
|
| Repayment Of Debt |
|
-0.16
-22.83%
|
-0.13
+29.83%
|
-0.18
+95.06%
|
-3.66
|
| Long Term Debt Issuance |
|
—
|
0.00
-100.00%
|
0.32
|
0.00
|
| Long Term Debt Payments |
|
-0.16
-22.83%
|
-0.13
+29.83%
|
-0.18
-19.87%
|
-0.15
|
| Net Long Term Debt Issuance |
|
-0.16
-22.83%
|
-0.13
-194.78%
|
0.13
+188.74%
|
-0.15
|
| Short Term Debt Issuance |
|
0.00
-100.00%
|
0.34
+40.82%
|
0.24
|
0.00
|
| Short Term Debt Payments |
|
—
|
—
|
0.00
+100.00%
|
-3.51
|
| Net Short Term Debt Issuance |
|
0.00
-100.00%
|
0.34
+40.82%
|
0.24
+106.98%
|
-3.51
|
| Net Common Stock Issuance |
|
0.96
-74.47%
|
3.77
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
-0.18
+26.56%
|
-0.24
|
—
|
—
|
| Changes In Cash |
|
-0.75
+16.13%
|
-0.89
-155.85%
|
1.60
+113.05%
|
-12.25
|
| Beginning Cash Position |
|
1.81
-33.07%
|
2.70
+145.23%
|
1.10
-91.75%
|
13.35
|
| End Cash Position |
|
1.06
-41.45%
|
1.81
-33.07%
|
2.70
+145.23%
|
1.10
|
| Free Cash Flow |
|
-1.38
+68.00%
|
-4.31
-9.61%
|
-3.93
-27.33%
|
-3.09
|
| Common Stock Issuance |
|
0.96
-74.47%
|
3.77
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
0.96
-74.47%
|
3.77
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-21 View
- 10-K2026-03-31 View
- 8-K2026-03-10 View
- 8-K2026-02-11 View
- 8-K2026-01-30 View
- 8-K2026-01-07 View
- 42025-12-29 View
- 8-K2025-12-11 View
- 8-K2025-11-24 View
- 8-K2025-11-12 View
- 10-Q2025-11-12 View
- 42025-11-07 View
- 42025-10-06 View
- 42025-10-06 View
- 42025-09-29 View
- 42025-08-29 View
- 10-Q2025-08-12 View
- 8-K2025-08-12 View
- 8-K2025-08-05 View
- 8-K2025-08-01 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|